triamcinolone acetonide has been researched along with nepafenac in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahrani, H; Fox, JE; Warren, KA | 1 |
| Kerci, SG; Küsbeci, T; Örsel, T; Sağban, L; Uzunel, UD; Yüksel, B | 1 |
| Bae, SS; Ching, G; Covello, AT; Holland, S; Iovieno, A; McCarthy, M; Ritenour, R; Yeung, SN | 1 |
| Al-Falah, M; Devenyi, R; Kertes, P; Lam, WC; Mandelcorn, ED; Zhao, LD | 1 |
| Do, A; Ertel, M; Huang, MJ; Larsen, CL; Levin, A; Panarelli, JF; Pantcheva, M; Samuelson, TW; Sheybani, A | 1 |
3 trial(s) available for triamcinolone acetonide and nepafenac
| Article | Year |
|---|---|
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzeneacetamides; Benzophenones; Bevacizumab; Bromobenzenes; Diclofenac; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ketorolac; Macular Edema; Male; Middle Aged; Phenylacetates; Pseudophakia; Retina; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Comparison of Subtenon Triamcinolone Acetonide Injection with Topical Nepafenac for the Treatment of Pseudophakic Cystoid Macular Edema.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Phenylacetates; Prospective Studies; Pseudophakia; Retina; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2017 |
A prospective randomized clinical trial comparing nepafenac, intravitreal triamcinolone and no adjuvant therapy for epiretinal membrane.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Epiretinal Membrane; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Phenylacetates; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2022 |
2 other study(ies) available for triamcinolone acetonide and nepafenac
| Article | Year |
|---|---|
Incidence and Outcomes of Cystoid Macular Edema after Descemet Membrane Endothelial Keratoplasty (DMEK) and DMEK Combined with Cataract Surgery.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract; Cataract Extraction; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Drug Therapy, Combination; Female; Humans; Incidence; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Prednisolone; Retrospective Studies; Risk Factors; Slit Lamp Microscopy; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2021 |
Extreme intraocular pressure and steroid-dependent iritis.
Topics: Acetazolamide; Female; Humans; Intraocular Pressure; Iritis; Latanoprost; Loteprednol Etabonate; Middle Aged; Triamcinolone Acetonide | 2023 |